Form 8-K - Current report:
SEC Accession No. 0001558370-25-008787
Filing Date
2025-06-23
Accepted
2025-06-23 08:55:54
Documents
13
Period of Report
2025-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K fbio-20250617x8k.htm   iXBRL 8-K 77272
  Complete submission text file 0001558370-25-008787.txt   228104

Data Files

Seq Description Document Type Size
2 EX-101.SCH fbio-20250617.xsd EX-101.SCH 4556
3 EX-101.DEF fbio-20250617_def.xml EX-101.DEF 14891
4 EX-101.LAB fbio-20250617_lab.xml EX-101.LAB 17166
5 EX-101.PRE fbio-20250617_pre.xml EX-101.PRE 14856
15 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20250617x8k_htm.xml XML 7218
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35366 | Film No.: 251063100
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)